Effect of cyclosporine A on the non-specific, innate antiviral immunity of mice

Archivum Immunologiae et Therapiae Experimentalis

Volumn 49, Issue SUPPL. 1, 2001, Pages

  Zaczyńska, Ewa ^a   Blach Olszewska, Zofia ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cyclosporine; Innate immunity; Viral infections

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DRUG EFFECT; FEMALE; IMMUNOLOGY; INNATE IMMUNITY; MOUSE; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CYCLOSPORINE; FEMALE; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0242508228     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. AKIYAMA H., YOSHINAGA H., TANAKA T., HIRUMA K., TANIKAWA S., SAKAMAKI H., ONOZAWA Y., WAKITA T. and KOHARA M. (1997): Effect of cyclosporine A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplant., 20, 993-995.
2. CHARAN S., HUEGIN A. W., CERNY A., HENGARTNER H. and ZINKERNAGEL R. M. (1986): Effect of cyclosporine A on humoral immune response and resistance against vesicular stomatitis virus in mice. J Virol., 57, 1139-1144.
3. COOK R. M. (1983): Activity of cyclosporin A in experimental influenza virus infection in mice. Agents Actions, 13, 98-100.
4. FISHMAN J. A. and RUBIN R. H. (1998): Infection in organ-transplant recipients. N. Engl. J. Med., 338, 1741-1751.
5. JANEWAY C. A. (1998): The road less travelled by: the role of innate immunity in the adaptive immune response. J. Immunol., 161, 539-544.
6. JOHANNESSEN I. and CRAWFORD D. H. (1999): In vivo models for Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disease (BLPD). Rev. Med. Virol., 9, 263-277.
7. MIEDZHITOV R. and JANEWAY C. A. (1997): Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol., 9, 4-9.
8. ORZECHOWSKA B., ANTOSZKÓW Z., JURKANIS I. and BŁACH-OLSZEWSKA Z. (1999): Innate antiviral immunity of human full blood cultures and lymphocytes; production of IFN and TNF. J. Interferon Cytokine Res., 19 (suppl. 1), S119.
9. ORZECHOWSKA B. and BŁACH-OLSZEWSKA Z. (1996): Acquirement of susceptibility to vesicular stomatitis virus infection by murine resident peritoneal cells during their culture in vitro. Arch. Immunol. Ther. Exp., 44, 325-328.
10. PARADOWSKA E., BŁACH-ULSZEWSKA Z., SENDER J. and JAROSZ W. (1996): Antiviral non specific immunity of human placenta at term. Possible role of endogenous tumor necrosis factors and interferons. J. Interferon Cytokine Res., 16, 941-947.
11. SCHILTKNECHT E. and ADA G. L. (1985): In vivo effect of cyclosporine on influenza A virus-infected mice. Cell. Immunol., 91, 227-239.
12. TANNER J. E. and ALFIERI C. (1996): Interactions involving cyclocporine A, interleukin 6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease. Leuk. Lymphoma, 21, 379-390.
13. ZACZYNSKA E., BŁACH-OLSZEWSKA Z. and GEJDEL E. (1995): Production of cytokines with antiviral activity by endothelial cells. J. Interferon Cytokine Res., 15, 811-814.